ALEXANDRA LEIS: Open Payments
NPI 1083099741 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 42 payments from 16 companies in 2025. Trend: 2023 $731 · 2024 $650 · 2025 $760
Food & beverage: $683Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $234 |
| GENZYME CORPORATION | 8 | $144 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $98 |
| LEO Pharma Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 1 | $34 |
| ABBVIE INC. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Cipher Pharmaceuticals US LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Biofrontera Inc. | 1 | $19 |
Products named: TREMFYA, DUPIXENT, ANZUPGO, Rhapsido, RINVOQ, ILUMYA, SPEVIGO, Natroba.
Industry payments across KY — which companies pay providers there.
